All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells

Istvan Arany, I. Ember, Stephen K. Tyring

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Earlier we observed that all-trans-retinoic acid (ATRA) dose-dependently suppressed the growth of cervical carcinoma cells. Suppression of growth required sustained activation of interferon regulatory factor 1 (IRF-1), which was achieved by high-dose (10-4 M), but not low-dose (10-6 M), ATRA treatment. In this paper we examine the role of IRF-1 in cell death that accompanied the growth suppression in high-dose ATRA-treated cells. We found that high-dose, but not low-dose, ATRA treatment activated caspase-1 in those cervical carcinoma cells. Transient transfection of an antisense-IRF-1 construct diminished high-dose ATRA-mediated caspase-1 activation. On the other hand, ATRA was not able to induce caspase-1 expression in a STAT1 (signal transducer and activator of transcription 1) knockout cell line, but transient transfection of STAT1 restored it. These results suggested the importance of both IRF-1 and STAT1 in high-dose ATRA-induced activation of caspase-1. Our results might be useful in the treatment of retinoid-resistant cervical neoplasias.

Original languageEnglish
Pages (from-to)471-473
Number of pages3
JournalAnticancer Research
Volume23
Issue number1 A
Publication statusPublished - Jan 2003

Fingerprint

Caspase 1
Tretinoin
Squamous Cell Carcinoma
Interferon Regulatory Factor-1
STAT1 Transcription Factor
Transfection
Growth
Carcinoma
Retinoids
Cell Death
Cell Line

Keywords

  • Caspase-1
  • Cervical
  • IRF-1
  • Retinoids
  • Squamous carcinoma cells
  • STAT1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells. / Arany, Istvan; Ember, I.; Tyring, Stephen K.

In: Anticancer Research, Vol. 23, No. 1 A, 01.2003, p. 471-473.

Research output: Contribution to journalArticle

@article{ea82736676c54eeb961b5ecb8188ecaf,
title = "All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells",
abstract = "Earlier we observed that all-trans-retinoic acid (ATRA) dose-dependently suppressed the growth of cervical carcinoma cells. Suppression of growth required sustained activation of interferon regulatory factor 1 (IRF-1), which was achieved by high-dose (10-4 M), but not low-dose (10-6 M), ATRA treatment. In this paper we examine the role of IRF-1 in cell death that accompanied the growth suppression in high-dose ATRA-treated cells. We found that high-dose, but not low-dose, ATRA treatment activated caspase-1 in those cervical carcinoma cells. Transient transfection of an antisense-IRF-1 construct diminished high-dose ATRA-mediated caspase-1 activation. On the other hand, ATRA was not able to induce caspase-1 expression in a STAT1 (signal transducer and activator of transcription 1) knockout cell line, but transient transfection of STAT1 restored it. These results suggested the importance of both IRF-1 and STAT1 in high-dose ATRA-induced activation of caspase-1. Our results might be useful in the treatment of retinoid-resistant cervical neoplasias.",
keywords = "Caspase-1, Cervical, IRF-1, Retinoids, Squamous carcinoma cells, STAT1",
author = "Istvan Arany and I. Ember and Tyring, {Stephen K.}",
year = "2003",
month = "1",
language = "English",
volume = "23",
pages = "471--473",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1 A",

}

TY - JOUR

T1 - All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells

AU - Arany, Istvan

AU - Ember, I.

AU - Tyring, Stephen K.

PY - 2003/1

Y1 - 2003/1

N2 - Earlier we observed that all-trans-retinoic acid (ATRA) dose-dependently suppressed the growth of cervical carcinoma cells. Suppression of growth required sustained activation of interferon regulatory factor 1 (IRF-1), which was achieved by high-dose (10-4 M), but not low-dose (10-6 M), ATRA treatment. In this paper we examine the role of IRF-1 in cell death that accompanied the growth suppression in high-dose ATRA-treated cells. We found that high-dose, but not low-dose, ATRA treatment activated caspase-1 in those cervical carcinoma cells. Transient transfection of an antisense-IRF-1 construct diminished high-dose ATRA-mediated caspase-1 activation. On the other hand, ATRA was not able to induce caspase-1 expression in a STAT1 (signal transducer and activator of transcription 1) knockout cell line, but transient transfection of STAT1 restored it. These results suggested the importance of both IRF-1 and STAT1 in high-dose ATRA-induced activation of caspase-1. Our results might be useful in the treatment of retinoid-resistant cervical neoplasias.

AB - Earlier we observed that all-trans-retinoic acid (ATRA) dose-dependently suppressed the growth of cervical carcinoma cells. Suppression of growth required sustained activation of interferon regulatory factor 1 (IRF-1), which was achieved by high-dose (10-4 M), but not low-dose (10-6 M), ATRA treatment. In this paper we examine the role of IRF-1 in cell death that accompanied the growth suppression in high-dose ATRA-treated cells. We found that high-dose, but not low-dose, ATRA treatment activated caspase-1 in those cervical carcinoma cells. Transient transfection of an antisense-IRF-1 construct diminished high-dose ATRA-mediated caspase-1 activation. On the other hand, ATRA was not able to induce caspase-1 expression in a STAT1 (signal transducer and activator of transcription 1) knockout cell line, but transient transfection of STAT1 restored it. These results suggested the importance of both IRF-1 and STAT1 in high-dose ATRA-induced activation of caspase-1. Our results might be useful in the treatment of retinoid-resistant cervical neoplasias.

KW - Caspase-1

KW - Cervical

KW - IRF-1

KW - Retinoids

KW - Squamous carcinoma cells

KW - STAT1

UR - http://www.scopus.com/inward/record.url?scp=0345268730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345268730&partnerID=8YFLogxK

M3 - Article

C2 - 12680251

AN - SCOPUS:0345268730

VL - 23

SP - 471

EP - 473

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1 A

ER -